Prenatal diagnosis in advanced maternal age. Amniocentesis or CVS, a patient's choice or lack of information?
Ninety-six women of advanced maternal age were interviewed about the way they obtained information on prenatal diagnosis and about how the decision was made as to what procedure was to be performed (transabdominal chorionic villus sampling (TA-CVS) or amniocentesis). In the CVS group, women visited their physician or midwife earlier in pregnancy (mean 7.1 weeks) than those in the amniocentesis group (mean 10.7 weeks). The availability of prenatal diagnosis was not mentioned during the first antenatal visit in 55 per cent of women from the amniocentesis group as opposed to 25 per cent from the TA-CVS group. Approximately 40 per cent of women eligible for prenatal diagnosis did not receive any information from the referring body prior to counselling at our centre. Only 29 per cent of women who underwent amniocentesis had actually chosen this procedure; 71 per cent were too late to undergo TA-CVS at 12 weeks. It is concluded that information to the patient must be improved in order to ensure early referral for prenatal diagnosis.
Brandenburg
H
H
Department of Obstetrics and Gynecology, Academic Hospital Rotterdam-Dijkzigt, Erasmus University Rotterdam, The Netherlands.
van der Zwan
L
L
Jahoda
M G
MG
Stijnen
T
T
Wladimiroff
J W
JW
D000328:Adult; D000649:Amniocentesis; D002755:Choice Behavior; D015193:Chorionic Villi Sampling; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D010342:Patient Acceptance of Health Care; D011247:Pregnancy; D011296:Prenatal Diagnosis